Novartis receives approval from European Commission for Farydak capsules
Novartis receives approval from European Commission for Farydak capsules
About this item
Full title
Novartis receives approval from European Commission for Farydak capsules
Publisher
London: Normans Media Ltd
Journal title
M2 Pharma, 2015
Language
English
Formats
Publication information
Publisher
London: Normans Media Ltd
Subjects
More information
Scope and Contents
Contents
M2PHARMA-September 8, 2015-Novartis receives approval from European Commission for Farydak capsules (C)2015 M2 COMMUNICATIONS http://www.m2.com It was reported yesterday that Novartis, a Swiss multinational pharmaceutical company, has received approval from the European Commission for Farydak (panobin...
Alternative Titles
Full title
Novartis receives approval from European Commission for Farydak capsules
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_1709996386
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_1709996386
How to access this item
Log in as a Library member
